Treatment with PRG can inhibit Th17 cell differentiation and pathogenicity by suppressing pathological Id2/Pim1 axis and GM-CSF signaling, further regulating the Th17/Treg imbalance and leading to the treatment of AU. Here, PIM1 is linked to alopecia universalis congenita.